XML 37 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Total revenues $ 866,863 $ 2,000,868 $ 3,832,442 $ 27,979,273
Operating expenses:        
Research and development 19,137,209 21,851,858 66,013,364 68,892,229
General and administrative 5,681,441 6,791,693 18,506,570 23,679,018
Total operating expenses 24,818,650 28,643,551 84,519,934 92,571,247
Loss from operations (23,951,787) (26,642,683) (80,687,492) (64,591,974)
Other income (expense):        
Interest income 637,438 565,039 2,018,302 1,648,987
Interest expense (2,428,671) 0 (5,279,702) 0
Change in fair value of common stock warrants 0 228,665 0 360,795
Change in fair value of derivative liability 2,551,453 0 2,551,453 0
Gain (loss) on investment in affiliated entities (485,841) 1,017,359 (1,409,156) 1,305,174
Other income (expense), net 140,956 (184,052) 232,629 (558,796)
Net loss before income tax benefit/(provision for income tax) (23,536,452) (25,015,672) (82,573,966) (61,835,814)
Income tax benefit/(provision for income taxes) 0 0 169,571 (2,169,811)
Net loss (23,536,452) (25,015,672) (82,404,395) (64,005,625)
Net loss attributable to non-controlling interest 445,759 0 707,214 0
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (23,090,693) $ (25,015,672) $ (81,697,181) $ (64,005,625)
Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders        
Basic (dollars per share) $ (0.23) $ (0.27) $ (0.83) $ (0.70)
Diluted (dollars per share) $ (0.25) $ (0.27) $ (0.83) $ (0.70)
Weighted average number of common shares outstanding        
Basic (shares) 99,007,985 92,423,122 98,204,375 91,350,117
Diluted (shares) 102,807,056 92,423,122 98,204,375 91,350,117
Revenue under collaborative research and development arrangements        
Revenues:        
Total revenues $ 617,427 $ 1,813,287 $ 3,452,422 $ 27,488,185
Revenue under collaborative research and development arrangements with affiliated entities        
Revenues:        
Total revenues 53,014 184,990 179,984 393,317
Miscellaneous revenue        
Revenues:        
Total revenues $ 196,422 $ 2,591 $ 200,036 $ 97,771